Systematic review and meta-analysis of the association between complementary factor H Y402H polymorphisms and age-related macular degeneration
暂无分享,去创建一个
Ammarin Thakkinstian | Mark McEvoy | Kang Zhang | John Attia | Josephine Hoh | J. Hoh | K. Magnússon | J. Attia | M. McEvoy | Kang Zhang | A. Thakkinstian | P. Han | Wayne T Smith | Kristinn P. Magnusson | Pearline Han | Wayne Smith | Kang Zhang | Kang Zhang | Pearline Han
[1] S. Rodríguez de Córdoba,et al. The human complement factor H: functional roles, genetic variations and disease associations. , 2004, Molecular immunology.
[2] C. Pang,et al. Differential occurrence of mutations causative of eye diseases in the Chinese population , 2002, Human mutation.
[3] J. Gilbert,et al. Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.
[4] J. Ott,et al. Lack of an association of apolipoprotein E gene polymorphisms with familial age-related macular degeneration. , 2003, Archives of ophthalmology.
[5] Douglas G. Altman,et al. Systematic reviews in health care : meta-analysis in context , 2008 .
[6] E. Souied,et al. Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population. , 2005, Molecular vision.
[7] Johannes R. Vingerling,et al. The prevalence of age-related maculopathy in the Rotterdam Study. , 1995, Ophthalmology.
[8] G. Abecasis,et al. Meta-analysis of genome scans of age-related macular degeneration. , 2005, Human molecular genetics.
[9] R. Klein,et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. , 2003, Ophthalmology.
[10] Ammarin Thakkinstian,et al. A method for meta‐analysis of molecular association studies , 2005, Statistics in medicine.
[11] R. Wormald,et al. Is the incidence of registrable age-related macular degeneration increasing? , 1996, The British journal of ophthalmology.
[12] M. Klein,et al. Heredity and age-related macular degeneration. Observations in monozygotic twins. , 1994, Archives of ophthalmology.
[13] R. T. Smith,et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[14] Jian Ge,et al. CFH Y402H Confers Similar Risk of Soft Drusen and Both Forms of Advanced AMD , 2005, PLoS medicine.
[15] S M Meyers,et al. A twin study of age-related macular degeneration. , 1995, American journal of ophthalmology.
[16] S. Santangelo,et al. A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. , 2003, American journal of human genetics.
[17] Margaret A. Pericak-Vance,et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease , 1997 .
[18] T. Matise,et al. Age-related macular degeneration--a genome scan in extended families. , 2003, American journal of human genetics.
[19] G. Silvestri,et al. Is genetic predisposition an important risk factor in age-related macular degeneration? , 1994, Eye.
[20] R. Klein,et al. A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study. , 2003, American journal of human genetics.
[21] A. Moore,et al. Genetic susceptibility to age related macular degeneration , 2000, Journal of medical genetics.
[22] Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. , 2004, American journal of human genetics.
[23] Jurg Ott,et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. , 2005, American journal of human genetics.
[24] S G Thompson,et al. Investigating underlying risk as a source of heterogeneity in meta-analysis. , 1997, Statistics in medicine.
[25] C. Klaver,et al. The genetics of age-related macular degeneration. , 1999, Molecular vision.
[26] J. Thompson,et al. The choice of a genetic model in the meta-analysis of molecular association studies. , 2005, International journal of epidemiology.
[27] M. Iannuzzi,et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. , 2003, American journal of human genetics.
[28] J. Haines,et al. Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. , 2004, American journal of human genetics.
[29] Familial Aggregation of Age-related Maculopathy , 1997 .
[30] S. Sharp,et al. Explaining heterogeneity in meta-analysis: a comparison of methods. , 1999 .
[31] G. Abecasis,et al. Age-Related Macular Degeneration: A High-Resolution Genome Scan for Susceptibility Loci in a Population Enriched for Late-Stage Disease , 2004 .
[32] L. V. Johnson,et al. Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. , 2001, Experimental eye research.
[33] A Hofman,et al. Genetic risk of age-related maculopathy. Population-based familial aggregation study. , 1998, Archives of ophthalmology.
[34] Harold Snieder,et al. Genetic influence on early age-related maculopathy: a twin study. , 2002, Ophthalmology.
[35] S. Russell,et al. Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] S. Sivaprasad,et al. The complement system and age-related macular degeneration , 2006, Eye.
[37] R. Klein,et al. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. , 1992, Ophthalmology.
[38] T. Matise,et al. Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. , 1998, Archives of ophthalmology.
[39] S. Fisher,et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk , 2005 .
[40] J. Eisman,et al. Meta‐Analysis of Molecular Association Studies: Vitamin D Receptor Gene Polymorphisms and BMD as a Case Study , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[41] J. Ott,et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.
[42] D. Clayton,et al. Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. , 2006, Investigative ophthalmology & visual science.
[43] Alston Callahan,et al. The role of inflammation in the pathogenesis of age-related macular degeneration. , 2006, Survey of ophthalmology.
[44] J. Haines,et al. A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy , 2002, Ophthalmic genetics.
[45] J. Haines,et al. Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .
[46] R. Klein,et al. Sibling correlations and segregation analysis of age‐related maculopathy: The beaver dam eye study , 1994, Genetic epidemiology.
[47] D. Weeks,et al. Age-related maculopathy: an expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions. , 2001, American journal of ophthalmology.
[48] P. Zandi,et al. Apolipoprotein E Genotype and Mortality: Findings from the Cache County Study , 2005, Journal of the American Geriatrics Society.
[49] S G Thompson,et al. Systematic Review: Why sources of heterogeneity in meta-analysis should be investigated , 1994, BMJ.
[50] Thomas A Trikalinos,et al. Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. , 2006, American journal of epidemiology.
[51] J. J. Wang,et al. The prevalence of age-related maculopathy: the visual impairment project. , 2000, Ophthalmology.
[52] A. Hofman,et al. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. , 2006, JAMA.
[53] Association Between C-Reactive Protein and Age-Related Macular Degeneration , 2004 .
[54] D. Weeks,et al. Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy. , 2005, Human molecular genetics.
[55] J. Haines,et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.
[56] B S Weir,et al. A disequilibrium coefficient approach to Hardy-Weinberg testing. , 1989, Biometrics.
[57] J. J. Wang,et al. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. , 1995, Ophthalmology.
[58] Douglas G. Altman,et al. Systematic Reviews in Health Care , 2001 .
[59] Ammarin Thakkinstian,et al. Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. , 2005, American journal of epidemiology.